Published 2 days ago • loading... • Updated 2 days ago

Longitude Rx Appoints Stacy Walton as Inaugural Chief Commercial Officer to Accelerate Growth and Market

On Tuesday, Longitude Rx appointed Stacy Walton as its inaugural Chief Commercial Officer to lead market access strategy, payer engagement, and health system growth.
Established in 2024, Longitude Rx is a health system-owned specialty pharmacy services organization; its founding members, including Providence and Michigan Medicine, represent more than $60 billion in combined net patient service revenue.
Walton brings more than 30 years of experience across specialty pharmacy and commercial strategy, having previously served as Senior Vice President at a firm supporting more than 80 health systems.
CEO Jigar Thakkar said, "Stacy brings exactly the combination of clinical credibility and commercial sophistication this role demands," noting she will unify market access and growth execution into a single commercial engine.
Walton stated that Longitude Rx is "building something genuinely different" by creating infrastructure that health systems own, adding she aims to "scale that model" for more health systems and patients.

Insights by Ground AI

19 Articles

WJFW NewsWatch 12

+17 Reposted by 17 other sources

Center

Longitude Rx Appoints Stacy Walton as Inaugural Chief Commercial Officer to Accelerate Growth and Market Expansion

IRVING, Texas, March 31, 2026 /PRNewswire/ -- Longitude Rx, the health system–owned specialty pharmacy services organization, today announced the appointment of Stacy Walton as its inaugural Chief Commercial Officer (CCO). Walton brings more than 30 years of experience across specialty…

2 days ago

Read Full Article